Flow Cytometry – News and Features

Bio-Matrix has entered into a contract with Validation Systems to finalize its FDA Good Manufacturing Practices Quality Systems documentation.

Researchers at Penn State will use GenoLogics’ Geneus and Proteus lab and data-management informatics software at multiple labs and multiple science domains.

University of Michigan researcher is working with the NCI to help find simpler ways of identifying the activity of stem cells within a tumor and testing its relation to whether the patient survives or dies.

The CytoGenie™ is a knowledge-based software tool that simplifies the design of multicolor flow cytometry experiments.

The Hospital for Sick Children Research Institute has selected Genologics’ Geneus™ to manage their genomics workflows and assist with collaborative stem cell research across nine labs.

ReNeuron files IND application to commence human clinical studies with ReN001 stem cell therapy for stroke.

Bio-Matrix’s stem cell processing laboratory now meets federal air control regulations to operate as a Class 10,000 clean Room.

Phase I clinical trial designed to evaluate the safety and preliminary efficacy of HuCNS-SC as a treatment for infantile and late infantile neuronal ceroid lipofuscinosis.

The Company believes this will be the first commercial adult stem cell processing and banking facility in the United States focused on stem cells derived from fat tissue.

The class 10,000 laboratory will now enter into the essential process towards full American Association of Tissue Banks accreditation.